Get started
MOREPEN LAB. LTDMOREPEN LAB. LTDMOREPEN LAB. LTD

MOREPEN LAB. LTD

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals

MOREPENLAB trade ideas

MOREPENLAB | Fibonacci retracement analysis. Morepen Lab Ltd. The price is currently near the support level and indicating a strong support zone. The long-term target, if reversal occurs, could be around ₹100.90 and beyond. Volume activity suggests recent selling pressure, but a bounce from this zone may trigger an upward move. Disclaimer: This is not financial advice. Please do your own research or consult with a financial advisor before making any investment decisions. Investments in stocks can be risky and may result in loss of capital.
NSE:MOREPENLABLong
by ProfitLossMereSath
1
Morepen Laboratories Trading IdeaIntroduction Morepen Laboratories Ltd. engages in the business of manufacturing bulk drugs, intermediates, and medical devices; and business of formulation. It operates through the following geographical segments: the United States of America, Rest of World, and India. Observation Stock Trade all the Ema making rounding bottom after a rejection from 72 level in 2021. now it is trying to breakout the same level once it breakout and sustain above 72 level no one can stop this stock to reach my levels which is 120. on weekly chart you'll see a gap up open marubozu candlestick stock look strong on all the TF. Get the inside scoop! Read the rest of the article on our blog 👆
NSE:MOREPENLABLong
by SHEHBAZ_KHAN
2
Morpen Laboratories Swing Trade Opportunity with Gain Tgt 49% ### Recommendation: Morpen Laboratories - **Type of Trade**: Swing Trade - **Entry Price**: Above 57 - **Short-term Stop Loss**: 52 - **WCB Targets**: 60, 71, 75, 85 - **Long-term Stop Loss**: 42 **Fundamentals of Morpen Laboratories**: Morpen Laboratories is a well-established pharmaceutical company with a strong presence in the Indian market. It specializes in the production of active pharmaceutical ingredients (APIs), formulations, and diagnostics. The company has a robust pipeline of products and has been expanding its market reach through strategic partnerships and new product launches. Recent financial reports indicate steady revenue growth and profitability. **Disclaimer**: I am not SEBI registered. Consult your financial advisor before making any investment decisions.
NSE:MOREPENLABLong
by TRADERSMONK07
Morepen: Burnol maker & Right wing In the past 10 years, one pharma company which has been in the midst of right wing discussion has been Gurgaon based Morepen Labs. It is into API, diagnostoc products and pain and acid reflux OTC medicines. But its known by its small revenue contributor - Burnol. Morepen is has become MorePain for the Left Liberals. Technically speaking it has shown higher volumes during election times and also has given 4x - 10x returns after the past two Lok sabha elections.
NSE:MOREPENLABLong
by SWFguy